Intuitive Surgical (NASDAQ:ISRG) had its price objective increased by Piper Jaffray Companies to $613.00 in a research report released on Friday, October 19th, The Fly reports. They currently have an overweight rating on the medical equipment provider’s stock.
ISRG has been the subject of several other reports. Morgan Stanley lifted their price target on Intuitive Surgical from $575.00 to $600.00 and gave the company an overweight rating in a report on Thursday, October 11th. Wells Fargo & Co boosted their target price on Intuitive Surgical from $575.00 to $635.00 and gave the stock an outperform rating in a report on Wednesday, September 12th. Bank of America boosted their target price on Intuitive Surgical from $510.00 to $600.00 and gave the stock a buy rating in a report on Tuesday, July 17th. Zacks Investment Research upgraded Intuitive Surgical from a hold rating to a buy rating and set a $582.00 target price for the company in a report on Tuesday, July 24th. Finally, Goldman Sachs Group boosted their target price on Intuitive Surgical from $540.00 to $630.00 and gave the stock a buy rating in a report on Friday, July 20th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seventeen have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus price target of $554.64.
Intuitive Surgical stock traded down $7.46 during midday trading on Friday, hitting $532.56. The company’s stock had a trading volume of 636,228 shares, compared to its average volume of 1,097,082. The stock has a market cap of $62.32 billion, a PE ratio of 74.07, a price-to-earnings-growth ratio of 3.66 and a beta of 1.02. Intuitive Surgical has a 12 month low of $359.75 and a 12 month high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. The company had revenue of $920.90 million for the quarter, compared to analysts’ expectations of $916.22 million. During the same quarter in the previous year, the business posted $2.77 EPS. The business’s revenue for the quarter was up 14.0% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical will post 9.52 EPS for the current fiscal year.
In other Intuitive Surgical news, EVP David J. Rosa sold 32,500 shares of the company’s stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $500.86, for a total value of $16,277,950.00. Following the sale, the executive vice president now directly owns 44,208 shares in the company, valued at $22,142,018.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Salvatore Brogna sold 2,652 shares of the company’s stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $557.39, for a total value of $1,478,198.28. Following the completion of the sale, the chief operating officer now owns 2,049 shares in the company, valued at $1,142,092.11. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 47,311 shares of company stock worth $24,144,846. 2.20% of the stock is currently owned by company insiders.
A number of large investors have recently made changes to their positions in the business. Jennison Associates LLC grew its holdings in shares of Intuitive Surgical by 773.4% during the third quarter. Jennison Associates LLC now owns 1,387,243 shares of the medical equipment provider’s stock worth $796,277,000 after purchasing an additional 1,228,418 shares during the last quarter. FMR LLC grew its holdings in shares of Intuitive Surgical by 19.2% during the second quarter. FMR LLC now owns 6,629,648 shares of the medical equipment provider’s stock worth $3,172,155,000 after purchasing an additional 1,068,107 shares during the last quarter. Morgan Stanley grew its holdings in shares of Intuitive Surgical by 88.1% during the second quarter. Morgan Stanley now owns 1,301,299 shares of the medical equipment provider’s stock worth $622,646,000 after purchasing an additional 609,465 shares during the last quarter. Summit Trail Advisors LLC grew its holdings in shares of Intuitive Surgical by 49,853.2% during the first quarter. Summit Trail Advisors LLC now owns 215,798 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 215,366 shares during the last quarter. Finally, Cornerstone Wealth Management LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth $341,000. Hedge funds and other institutional investors own 84.16% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Featured Article: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.